Atricure, Inc. operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Atricure with three other
companies in this sector in the United States:
sales of $143.49 million
of which 42%
was Fluid Delivery),
Cardiovascular Systems, Incorporation
of which 100%
was Diamondback), and
of which 63%
was Medical Devices).
Atricure reported sales of $155.11 million
December of 2016.
increase of 19.5%
versus 2015, when the company's sales were $129.76 million.
Sales at Atricure have increased during each of the previous five years
(and since 2011, sales have increased a total of 141%).